Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2003-09-04 Regulatory Filings
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Stratec Biomedical Sys.
Regulatory Filings Classification · 1% confidence The document is a short corporate news release dated September 4, 2003, announcing a milestone achievement: the delivery of the 100th PlateRunner-based system, which expands the company's position in the blood bank sector. It details the systems provided to partners (Galileo and daVINCI) and includes standard company boilerplate information and investor relations contact details. The text is clearly a general announcement about business operations and achievements, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed management discussion (MDA). Given its nature as a general corporate update distributed via a news service (DGAP), and since it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news announcements that are not otherwise classified.
2003-09-04 German
Stratec Biomedical Sys. english
Earnings Release Classification · 1% confidence The document is explicitly labeled as an "Ad-hoc-announcement" and is a "precautionary announcement of the results for the first half year of 2003, ending on June 30, 2003." It provides key financial highlights (Sales, EBITDA, Net income) for the six-month period (01/01/03-06/30/03) and explicitly states that the detailed interim report will be released later. This structure—a brief, early announcement of key figures for a period shorter than a year—fits the definition of an Earnings Release (ER). While it contains interim results, the primary function here is the immediate release of highlights, not the comprehensive report itself (which would be classified as IR). The document length (3243 chars) also supports it being a release/announcement rather than a full report. H1 2003
2003-07-29 English
Stratec Biomedical Sys. english
Earnings Release Classification · 1% confidence The document is explicitly labeled as an 'Ad-hoc-announcement' transmitted by DGAP, which is a common format for German regulatory disclosures. It provides a 'precautionary announcement of the results for the first quarter of 2003' including key financial figures (Sales, EBITDA, Net income, EPS) and compares them to the previous year. This content strongly aligns with an initial release of periodic financial results. Although it mentions that the 'more extensive interim report can be downloaded,' the document itself is the announcement of the results, not the full report. Therefore, it fits the definition of an Earnings Release (ER). The document length (3439 chars) is short, supporting the idea that it is an announcement rather than a comprehensive report (like an IR or 10-K). Q1 2003
2003-05-14 English
Stratec Biomedical Sys.
Legal Proceedings Report Classification · 1% confidence The document is a corporate news release dated May 2, 2003, detailing that the Mannheim public prosecutor's office has filed charges against a board member of STRATEC Biomedical Systems AG for alleged violations of securities trading law (insider trading/market manipulation related to the 1998 IPO). The text focuses on the legal proceedings, the company's defense against the allegations, and statements from management regarding the charges being directed at individuals, not the company itself. This content directly relates to significant legal matters involving the company. Therefore, it fits best under the 'Legal Proceedings Report' category (LTR). It is not an earnings release (ER), a formal regulatory filing like 10-K, or a management discussion (MDA), but a specific update on litigation.
2003-05-02 German
Stratec Biomedical Sys.
Director's Dealing Classification · 1% confidence The document text explicitly contains the header "Directors’ Dealings" and the German equivalent "Director’s-Dealings-Mitteilung". It details a transaction (Kauf/Verkauf: Kauf) by a member of the management ('Funktion: Geschäftsführendes Organ') in the company's shares, including the date, price, and quantity. This directly matches the definition for Director's Dealing (DIRS). The document length is short (1178 chars), but it is the report/notification itself, not an announcement of a report.
2003-04-16 German
Stratec Biomedical Sys.
Earnings Release Classification · 1% confidence The document text is a corporate news release dated March 25, 2003, detailing preliminary, unaudited financial results for the fiscal year 2002. It explicitly states key performance indicators like revenue, net profit, and EPS, and mentions that the final figures will be announced at the 'Bilanzpressekonferenz' (Balance Sheet Press Conference) on April 25, 2003. The content focuses on the initial announcement of periodical financial results (annual results) rather than being the full, audited Annual Report (10-K) or a comprehensive Interim Report (IR). This structure strongly aligns with an Earnings Release (ER). Although it mentions the full annual report will be distributed later, this specific document is the initial release of the results. FY 2002
2003-03-25 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.